Data on sex differences in one-year outcomes of out-of-hospital cardiac arrest patients without ST-segment elevation.
Coronary angiography
One-year outcomes
Out-of-hospital cardiac arrest
Sex differences
Journal
Data in brief
ISSN: 2352-3409
Titre abrégé: Data Brief
Pays: Netherlands
ID NLM: 101654995
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
27
10
2020
accepted:
09
11
2020
entrez:
9
12
2020
pubmed:
10
12
2020
medline:
10
12
2020
Statut:
epublish
Résumé
Sex differences in out-of-hospital cardiac arrest (OHCA) patients are increasingly recognized. Although it has been found that post-resuscitated women are less likely to have significant coronary artery disease (CAD) than men, data on follow-up in these patients are limited. Data for this data in brief article was obtained as a part of the randomized controlled Coronary Angiography after Cardiac Arrest without ST-segment elevation (COACT) trial. The data supplements the manuscript "Sex differences in out-of-hospital cardiac arrest patients without ST-segment elevation: A COACT trial substudy" were it was found that women were less likely to have significant CAD including chronic total occlusions, and had worse survival when CAD was present. The dataset presented in this paper describes sex differences on interventions, implantable-cardioverter defibrillator (ICD) shocks and hospitalizations due to heart failure during one-year follow-up in patients successfully resuscitated after OHCA. Data was derived through a telephone interview at one year with the patient or general practitioner. Patients in this randomized dataset reflects a homogenous study population, which can be valuable to further build on research regarding long-term sex differences and to further improve cardiac care.
Identifiants
pubmed: 33294518
doi: 10.1016/j.dib.2020.106521
pii: S2352-3409(20)31403-7
pmc: PMC7691722
doi:
Types de publication
Journal Article
Langues
eng
Pagination
106521Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
Supported by unrestricted research grants from the Netherlands Heart Institute, Biotronik, and AstraZeneca. Dr. Vlachojannis reports receiving grant support from MicroPort Orthopedics and Daiichi Sankyo; and Dr. van Royen, receiving grant support from Philips, Biotronik, and Abbott and honoraria from Medtronic. No other potential conflict of interest relevant to this article was reported.
Références
Intensive Care Med. 2015 Dec;41(12):2039-56
pubmed: 26464394
Am Heart J. 2016 Oct;180:39-45
pubmed: 27659881
N Engl J Med. 2019 Apr 11;380(15):1397-1407
pubmed: 30883057
JAMA Cardiol. 2020 Sep 2;:
pubmed: 32876654